In addition to wild type α-synuclein oligomers, we also analyzed the effects of oligomers formed by α-synuclein variants with nonsynonymous point mutations associated with autosomal dominant forms of Parkinson’s disease, which are reported to promote dimerization (A30P, E46K, A53T)69. Here, SNCA is linked to Parkinson disease.